Empro Group Inc. filed a Form F-1 registration statement for an initial public offering on 2024-09-16. It has amended it 11 times. It filed its final prospectus on 2025-07-02, at a public offering price of $4.00 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have received the approval from Nasdaq to list our Ordinary Shares on the Nasdaq Capital Market under the symbol “EMPG.”From the 424B4 filed 2025-07-02
Offering price
on an as adjusted basis to reflect the issuance and sale of the Ordinary Shares by us in this offering at an initial public offering price of $4.00 per share, after deducting the estimated underwriting discounts, and the estimated offering expenses payable by us.From the 424B4 filed 2025-07-02
Use of proceeds
We plan to use the net proceeds we receive from this offering for the following purposes:From the 424B4 filed 2025-07-02
Revenue
For the fiscal years ended December 31, 2024, 2023 and 2022, our total revenue was approximately $5.48 million, $3.70 million and $10.82 million, respectively, our revenue from our health care business segment was approximately $2.12 million, $3.32 million and $10.55 million, respectively, and our revenue from our cosmetics and skin care business segment was approximately $3.36 million, $0.38 million and $0.27 million, respectively.From the F-1/A filed 2025-06-04
Net loss or income
Also, for the fiscal year ended December 31, 2024 we had a net profit of approximately $0.75 million, and for the fiscal year ended December 31, 2023 we experienced a net loss of approximately $0.32 million.From the F-1/A filed 2025-06-04
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-09-16 | Registration statement filed (foreign issuer) | F-1 |
| 2024-10-16 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-11-15 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-10 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-01-22 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-02-07 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-03-31 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-09 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-20 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-22 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-27 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-06-04 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-07-02 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Empro Group Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.